Search

Your search keyword '"Essex, Sarah"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Essex, Sarah" Remove constraint Author: "Essex, Sarah"
32 results on '"Essex, Sarah"'

Search Results

1. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

2. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

3. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

4. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

5. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

6. Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

8. Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission

9. Genomic epidemiology of SARS-CoV-2 in a university outbreak setting and implications for public health planning

10. COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

11. Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission

12. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

13. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

14. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK — a multicentre observational study

15. The clinical course of COVID‐19 in pregnant versus non‐pregnant women requiring hospitalisation: results from the multicentre UK CA‐COVID‐19 study

16. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

17. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

18. Clinical Outcomes and the Impact of Oral Anticoagulants Prior to Diagnosis of COVID-19 on Clinical Outcomes in Patients Admitted to Hospitals in the UK – a Multicentre Observational Study

19. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

21. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK — a multicentre observational study.

22. Correlation of vibrational and electronic spectra. 1. Vibronic intensity distributions and ligand-field strengths in d-d spectra of five planar CuCl2X2 chromophores

23. IgG1 is required for optimal protection after immunization with the purified porin OmpD from Salmonella typhimurium

24. IgG1 Is Required for Optimal Protection after Immunization with the Purified Porin OmpD from Salmonella Typhimurium

27. Elevated Chemokine Expression in the Bone Marrow of Patients with Myeloma and MGUS Is Associated with Marked Alterations in the Distribution of CD4+ and CD8+ T Cell Subsets within the Blood and Bone Marrow

28. Fibroblastic Reticular Cells From Lymph Nodes Attenuate T Cell Expansion by Producing Nitric Oxide

31. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

32. IgG1 Is Required for Optimal Protection after Immunization with the Purified Porin OmpD from Salmonella Typhimurium.

Catalog

Books, media, physical & digital resources